本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Conduit Pharmaceuticals Inc.

1.78
+0.01000.56%
成交量:10.28萬
成交額:18.01萬
市值:428.11萬
市盈率:-0.01
高:1.79
開:1.77
低:1.70
收:1.77
資料載入中...
2024/12/17

重要事件披露

Form 8-K - Current report
2024/12/04

SEC問詢函

Form CORRESP - Correspondence
2024/11/25

重要事件披露

Form 8-K - Current report
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/06

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

重要事件披露

Form 8-K - Current report
2024/10/31

SEC問詢函

Form CORRESP - Correspondence
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/16

重要事件披露

Form 8-K - Current report
2024/10/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/19

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/16

SEC問詢函

Form CORRESP - Correspondence
2024/09/13

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/06

重要事件披露

Form 8-K - Current report
2024/09/04

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933